Advances include improved sensitivity of diagnostic imaging, development of multiple immunohistochemistry markers that distinguish disease origin, and clinical acknowledgment of the need for pathologic confirmation of recurrence
doxycycline mechanism of action Serious Use Alternative 1 rifapentine decreases levels of vemurafenib by affecting hepatic intestinal enzyme CYP3A4 metabolism